The objective of this study is to develop magnetic resonance imaging (MRI) biomarkers that can probe complementary vascular function and myelin content. The development of biomarker assays to quantitatively probe both perfusion and myelin content is critical to assessing acute inflammatory activity and regenerative potential. We anticipate that this biomarker will give insight into the underlying pathophysiology of reversible and irreversible myelin damage.
This abstract and the presentation materials are available to members only; a login is required.